Advertisement

Index by author

December 01, 1994; Volume 46,Issue 6

A

  1. Abdel-Razzak, Z

    1. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.
      Z Abdel-Razzak, L Corcos, A Fautrel, J P Campion and A Guillouzo
      Molecular Pharmacology December 1994, 46 (6) 1100-1110;

  2. Adan, R A

    1. Differential effects of melanocortin peptides on neural melanocortin receptors.
      R A Adan, R D Cone, J P Burbach and W H Gispen
      Molecular Pharmacology December 1994, 46 (6) 1182-1190;

  3. Agbaria, R

    1. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
      H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
      Molecular Pharmacology December 1994, 46 (6) 1063-1069;

  4. Ahlers, A

    1. Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells.
      A Ahlers, C Belka, M Gaestel, N Lamping, C Sott, F Herrmann and M A Brach
      Molecular Pharmacology December 1994, 46 (6) 1077-1083;

  5. Ailhaud, G

    1. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
      A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
      Molecular Pharmacology December 1994, 46 (6) 1070-1076;

  6. Amri, E Z

    1. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
      A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
      Molecular Pharmacology December 1994, 46 (6) 1070-1076;

  7. Aylwin, M L

    1. Gating properties of mutant acetylcholine receptors.
      M L Aylwin and M M White
      Molecular Pharmacology December 1994, 46 (6) 1149-1155;

B

  1. Barker, J L

    1. gamma-Aminobutyric acid type A receptor antagonists picrotoxin and bicuculline alter acetylcholine channel kinetics in cultured embryonic rat skeletal muscle.
      Q Y Liu, V Dunlap and J L Barker
      Molecular Pharmacology December 1994, 46 (6) 1197-1203;

  2. Battaglia, G

    1. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
      W Pinto and G Battaglia
      Molecular Pharmacology December 1994, 46 (6) 1111-1119;

  3. Befort, K

    1. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
      F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
      Molecular Pharmacology December 1994, 46 (6) 1015-1021;

  4. Belka, C

    1. Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells.
      A Ahlers, C Belka, M Gaestel, N Lamping, C Sott, F Herrmann and M A Brach
      Molecular Pharmacology December 1994, 46 (6) 1077-1083;

  5. Blanton, M P

    1. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
      M P Blanton, Y M Li, E R Stimson, J E Maggio and J B Cohen
      Molecular Pharmacology December 1994, 46 (6) 1048-1055;

  6. Bloomenthal, A B

    1. Biphasic modulation of the strychnine-sensitive glycine receptor by Zn2+.
      A B Bloomenthal, E Goldwater, D B Pritchett and N L Harrison
      Molecular Pharmacology December 1994, 46 (6) 1156-1159;

  7. Bochkov, V N

    1. Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction.
      V A Tkachuk, Y S Kuzmenko, T J Resink, D V Stambolsky and V N Bochkov
      Molecular Pharmacology December 1994, 46 (6) 1129-1137;

  8. Brach, M A

    1. Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells.
      A Ahlers, C Belka, M Gaestel, N Lamping, C Sott, F Herrmann and M A Brach
      Molecular Pharmacology December 1994, 46 (6) 1077-1083;

  9. Burbach, J P

    1. Differential effects of melanocortin peptides on neural melanocortin receptors.
      R A Adan, R D Cone, J P Burbach and W H Gispen
      Molecular Pharmacology December 1994, 46 (6) 1182-1190;

C

  1. Cachelin, A B

    1. Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing beta 4 subunits.
      A B Cachelin and G Rust
      Molecular Pharmacology December 1994, 46 (6) 1168-1174;

  2. Campion, J P

    1. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.
      Z Abdel-Razzak, L Corcos, A Fautrel, J P Campion and A Guillouzo
      Molecular Pharmacology December 1994, 46 (6) 1100-1110;

  3. Caput, D

    1. Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864.
      R Farges, E Joseph-Liauzun, D Shire, D Caput, G Le Fur and P Ferrara
      Molecular Pharmacology December 1994, 46 (6) 1160-1167;

  4. Castle, N A

    1. 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
      N A Castle, S R Fadous, D E Logothetis and G K Wang
      Molecular Pharmacology December 1994, 46 (6) 1175-1181;

  5. Cawthorne, M A

    1. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
      A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
      Molecular Pharmacology December 1994, 46 (6) 1070-1076;

  6. Challiss, R A

    1. Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m1 muscarinic receptors.
      S Jenkinson, S R Nahorski and R A Challiss
      Molecular Pharmacology December 1994, 46 (6) 1138-1148;

  7. Chen, K

    1. Cloning of a novel monoamine oxidase cDNA from trout liver.
      K Chen, H F Wu, J Grimsby and J C Shih
      Molecular Pharmacology December 1994, 46 (6) 1226-1233;

  8. Cohen, J B

    1. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
      M P Blanton, Y M Li, E R Stimson, J E Maggio and J B Cohen
      Molecular Pharmacology December 1994, 46 (6) 1048-1055;

  9. Collins, J M

    1. Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells.
      R W Klecker, A G Katki and J M Collins
      Molecular Pharmacology December 1994, 46 (6) 1204-1209;

  10. Cone, R D

    1. Differential effects of melanocortin peptides on neural melanocortin receptors.
      R A Adan, R D Cone, J P Burbach and W H Gispen
      Molecular Pharmacology December 1994, 46 (6) 1182-1190;

  11. Cooney, D A

    1. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
      H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
      Molecular Pharmacology December 1994, 46 (6) 1063-1069;

  12. Corcos, L

    1. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.
      Z Abdel-Razzak, L Corcos, A Fautrel, J P Campion and A Guillouzo
      Molecular Pharmacology December 1994, 46 (6) 1100-1110;

D

  1. Díaz, R S

    1. Thallium mediates a rapid chloride/hydroxyl ion exchange through myelin lipid bilayers.
      R S Díaz and J Monreal
      Molecular Pharmacology December 1994, 46 (6) 1210-1216;

  2. Dunlap, V

    1. gamma-Aminobutyric acid type A receptor antagonists picrotoxin and bicuculline alter acetylcholine channel kinetics in cultured embryonic rat skeletal muscle.
      Q Y Liu, V Dunlap and J L Barker
      Molecular Pharmacology December 1994, 46 (6) 1197-1203;

  3. Dyroff, M C

    1. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
      S W Grimm, M C Dyroff, R M Philpot and J R Halpert
      Molecular Pharmacology December 1994, 46 (6) 1090-1099;

F

  1. Fadous, S R

    1. 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
      N A Castle, S R Fadous, D E Logothetis and G K Wang
      Molecular Pharmacology December 1994, 46 (6) 1175-1181;

  2. Faiman, M D

    1. Glutathione- and glutathione-S-transferase-dependent oxidative desulfuration of the thione xenobiotic diethyldithiocarbamate methyl ester.
      A Madan, T D Williams and M D Faiman
      Molecular Pharmacology December 1994, 46 (6) 1217-1225;

  3. Farges, R

    1. Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864.
      R Farges, E Joseph-Liauzun, D Shire, D Caput, G Le Fur and P Ferrara
      Molecular Pharmacology December 1994, 46 (6) 1160-1167;

  4. Fautrel, A

    1. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.
      Z Abdel-Razzak, L Corcos, A Fautrel, J P Campion and A Guillouzo
      Molecular Pharmacology December 1994, 46 (6) 1100-1110;

  5. Ferrara, P

    1. Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864.
      R Farges, E Joseph-Liauzun, D Shire, D Caput, G Le Fur and P Ferrara
      Molecular Pharmacology December 1994, 46 (6) 1160-1167;

  6. Ferrari-Dileo, G

    1. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
      G Ferrari-Dileo, M Waelbroeck, D C Mash and D D Flynn
      Molecular Pharmacology December 1994, 46 (6) 1028-1035;

  7. Flynn, D D

    1. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
      G Ferrari-Dileo, M Waelbroeck, D C Mash and D D Flynn
      Molecular Pharmacology December 1994, 46 (6) 1028-1035;

  8. Fornace, A J

    1. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
      H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
      Molecular Pharmacology December 1994, 46 (6) 1063-1069;

G

  1. Gaestel, M

    1. Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells.
      A Ahlers, C Belka, M Gaestel, N Lamping, C Sott, F Herrmann and M A Brach
      Molecular Pharmacology December 1994, 46 (6) 1077-1083;

  2. Gaillard, D

    1. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
      A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
      Molecular Pharmacology December 1994, 46 (6) 1070-1076;

  3. Gasiewicz, T A

    1. Purification to homogeneity of the heteromeric DNA-binding form of the aryl hydrocarbon receptor from rat liver.
      E C Henry, G Rucci and T A Gasiewicz
      Molecular Pharmacology December 1994, 46 (6) 1022-1027;

  4. Gavériaux-Ruff, C

    1. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
      F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
      Molecular Pharmacology December 1994, 46 (6) 1015-1021;

  5. Gispen, W H

    1. Differential effects of melanocortin peptides on neural melanocortin receptors.
      R A Adan, R D Cone, J P Burbach and W H Gispen
      Molecular Pharmacology December 1994, 46 (6) 1182-1190;

  6. Goldwater, E

    1. Biphasic modulation of the strychnine-sensitive glycine receptor by Zn2+.
      A B Bloomenthal, E Goldwater, D B Pritchett and N L Harrison
      Molecular Pharmacology December 1994, 46 (6) 1156-1159;

  7. Grimaldi, P A

    1. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
      A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
      Molecular Pharmacology December 1994, 46 (6) 1070-1076;

  8. Grimm, S W

    1. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
      S W Grimm, M C Dyroff, R M Philpot and J R Halpert
      Molecular Pharmacology December 1994, 46 (6) 1090-1099;

  9. Grimsby, J

    1. Cloning of a novel monoamine oxidase cDNA from trout liver.
      K Chen, H F Wu, J Grimsby and J C Shih
      Molecular Pharmacology December 1994, 46 (6) 1226-1233;

  10. Guillouzo, A

    1. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.
      Z Abdel-Razzak, L Corcos, A Fautrel, J P Campion and A Guillouzo
      Molecular Pharmacology December 1994, 46 (6) 1100-1110;

H

  1. Halpert, J R

    1. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
      S W Grimm, M C Dyroff, R M Philpot and J R Halpert
      Molecular Pharmacology December 1994, 46 (6) 1090-1099;

  2. Hargreaves, A C

    1. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors.
      A C Hargreaves, S C Lummis and C W Taylor
      Molecular Pharmacology December 1994, 46 (6) 1120-1128;

  3. Harrison, N L

    1. Biphasic modulation of the strychnine-sensitive glycine receptor by Zn2+.
      A B Bloomenthal, E Goldwater, D B Pritchett and N L Harrison
      Molecular Pharmacology December 1994, 46 (6) 1156-1159;

  4. Henry, E C

    1. Purification to homogeneity of the heteromeric DNA-binding form of the aryl hydrocarbon receptor from rat liver.
      E C Henry, G Rucci and T A Gasiewicz
      Molecular Pharmacology December 1994, 46 (6) 1022-1027;

  5. Herrmann, F

    1. Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells.
      A Ahlers, C Belka, M Gaestel, N Lamping, C Sott, F Herrmann and M A Brach
      Molecular Pharmacology December 1994, 46 (6) 1077-1083;

I

  1. Ibrahimi, A

    1. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
      A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
      Molecular Pharmacology December 1994, 46 (6) 1070-1076;

  2. Izumi, F

    1. Correlation of activation of Ca2+/calmodulin-dependent protein kinase II with catecholamine secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells.
      M Tsutsui, N Yanagihara, E Miyamoto, A Kuroiwa and F Izumi
      Molecular Pharmacology December 1994, 46 (6) 1041-1047;

J

  1. Jenkinson, S

    1. Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m1 muscarinic receptors.
      S Jenkinson, S R Nahorski and R A Challiss
      Molecular Pharmacology December 1994, 46 (6) 1138-1148;

  2. Johns, D G

    1. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
      H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
      Molecular Pharmacology December 1994, 46 (6) 1063-1069;

  3. Joseph-Liauzun, E

    1. Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864.
      R Farges, E Joseph-Liauzun, D Shire, D Caput, G Le Fur and P Ferrara
      Molecular Pharmacology December 1994, 46 (6) 1160-1167;

K

  1. Katki, A G

    1. Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells.
      R W Klecker, A G Katki and J M Collins
      Molecular Pharmacology December 1994, 46 (6) 1204-1209;

  2. Kemp, J A

    1. Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex.
      T Priestley and J A Kemp
      Molecular Pharmacology December 1994, 46 (6) 1191-1196;

  3. Kieffer, B

    1. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
      F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
      Molecular Pharmacology December 1994, 46 (6) 1015-1021;

  4. Klecker, R W

    1. Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells.
      R W Klecker, A G Katki and J M Collins
      Molecular Pharmacology December 1994, 46 (6) 1204-1209;

  5. Kule, C

    1. Doxorubicin, daunorubicin, and mitoxantrone cytotoxicity in yeast.
      C Kule, O Ondrejickova and K Verner
      Molecular Pharmacology December 1994, 46 (6) 1234-1240;

  6. Kuroiwa, A

    1. Correlation of activation of Ca2+/calmodulin-dependent protein kinase II with catecholamine secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells.
      M Tsutsui, N Yanagihara, E Miyamoto, A Kuroiwa and F Izumi
      Molecular Pharmacology December 1994, 46 (6) 1041-1047;

  7. Kuzmenko, Y S

    1. Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction.
      V A Tkachuk, Y S Kuzmenko, T J Resink, D V Stambolsky and V N Bochkov
      Molecular Pharmacology December 1994, 46 (6) 1129-1137;

L

  1. Lamping, N

    1. Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells.
      A Ahlers, C Belka, M Gaestel, N Lamping, C Sott, F Herrmann and M A Brach
      Molecular Pharmacology December 1994, 46 (6) 1077-1083;

  2. Lannes, B

    1. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
      F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
      Molecular Pharmacology December 1994, 46 (6) 1015-1021;

  3. Le Fur, G

    1. Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864.
      R Farges, E Joseph-Liauzun, D Shire, D Caput, G Le Fur and P Ferrara
      Molecular Pharmacology December 1994, 46 (6) 1160-1167;

  4. Li, Y M

    1. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
      M P Blanton, Y M Li, E R Stimson, J E Maggio and J B Cohen
      Molecular Pharmacology December 1994, 46 (6) 1048-1055;

  5. Liu, Q Y

    1. gamma-Aminobutyric acid type A receptor antagonists picrotoxin and bicuculline alter acetylcholine channel kinetics in cultured embryonic rat skeletal muscle.
      Q Y Liu, V Dunlap and J L Barker
      Molecular Pharmacology December 1994, 46 (6) 1197-1203;

  6. Logothetis, D E

    1. 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
      N A Castle, S R Fadous, D E Logothetis and G K Wang
      Molecular Pharmacology December 1994, 46 (6) 1175-1181;

  7. Lummis, S C

    1. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors.
      A C Hargreaves, S C Lummis and C W Taylor
      Molecular Pharmacology December 1994, 46 (6) 1120-1128;

  8. Lyon, T

    1. Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells.
      G Wong, T Lyon and P Skolnick
      Molecular Pharmacology December 1994, 46 (6) 1056-1062;

M

  1. Madan, A

    1. Glutathione- and glutathione-S-transferase-dependent oxidative desulfuration of the thione xenobiotic diethyldithiocarbamate methyl ester.
      A Madan, T D Williams and M D Faiman
      Molecular Pharmacology December 1994, 46 (6) 1217-1225;

  2. Maggio, J E

    1. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
      M P Blanton, Y M Li, E R Stimson, J E Maggio and J B Cohen
      Molecular Pharmacology December 1994, 46 (6) 1048-1055;

  3. Makino, I

    1. Paradoxical derepression of collagenase gene expression by the antirheumatic gold compound aurothiomalate.
      Y Makino, H Tanaka and I Makino
      Molecular Pharmacology December 1994, 46 (6) 1084-1089;

  4. Makino, Y

    1. Paradoxical derepression of collagenase gene expression by the antirheumatic gold compound aurothiomalate.
      Y Makino, H Tanaka and I Makino
      Molecular Pharmacology December 1994, 46 (6) 1084-1089;

  5. Mash, D C

    1. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
      G Ferrari-Dileo, M Waelbroeck, D C Mash and D D Flynn
      Molecular Pharmacology December 1994, 46 (6) 1028-1035;

  6. Matthes, H

    1. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
      F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
      Molecular Pharmacology December 1994, 46 (6) 1015-1021;

  7. Micheletti, G

    1. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
      F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
      Molecular Pharmacology December 1994, 46 (6) 1015-1021;

  8. Miyamoto, E

    1. Correlation of activation of Ca2+/calmodulin-dependent protein kinase II with catecholamine secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells.
      M Tsutsui, N Yanagihara, E Miyamoto, A Kuroiwa and F Izumi
      Molecular Pharmacology December 1994, 46 (6) 1041-1047;

  9. Monreal, J

    1. Thallium mediates a rapid chloride/hydroxyl ion exchange through myelin lipid bilayers.
      R S Díaz and J Monreal
      Molecular Pharmacology December 1994, 46 (6) 1210-1216;

N

  1. Nahorski, S R

    1. Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m1 muscarinic receptors.
      S Jenkinson, S R Nahorski and R A Challiss
      Molecular Pharmacology December 1994, 46 (6) 1138-1148;

  2. Nappey, V

    1. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
      F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
      Molecular Pharmacology December 1994, 46 (6) 1015-1021;

O

  1. Ondrejickova, O

    1. Doxorubicin, daunorubicin, and mitoxantrone cytotoxicity in yeast.
      C Kule, O Ondrejickova and K Verner
      Molecular Pharmacology December 1994, 46 (6) 1234-1240;

  2. Osawa, S

    1. The carboxyl terminus of bovine rhodopsin is not required for G protein activation.
      S Osawa and E R Weiss
      Molecular Pharmacology December 1994, 46 (6) 1036-1040;

P

  1. Philpot, R M

    1. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
      S W Grimm, M C Dyroff, R M Philpot and J R Halpert
      Molecular Pharmacology December 1994, 46 (6) 1090-1099;

  2. Pinto, W

    1. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
      W Pinto and G Battaglia
      Molecular Pharmacology December 1994, 46 (6) 1111-1119;

  3. Priestley, T

    1. Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex.
      T Priestley and J A Kemp
      Molecular Pharmacology December 1994, 46 (6) 1191-1196;

  4. Pritchett, D B

    1. Biphasic modulation of the strychnine-sensitive glycine receptor by Zn2+.
      A B Bloomenthal, E Goldwater, D B Pritchett and N L Harrison
      Molecular Pharmacology December 1994, 46 (6) 1156-1159;

R

  1. Resink, T J

    1. Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction.
      V A Tkachuk, Y S Kuzmenko, T J Resink, D V Stambolsky and V N Bochkov
      Molecular Pharmacology December 1994, 46 (6) 1129-1137;

  2. Rucci, G

    1. Purification to homogeneity of the heteromeric DNA-binding form of the aryl hydrocarbon receptor from rat liver.
      E C Henry, G Rucci and T A Gasiewicz
      Molecular Pharmacology December 1994, 46 (6) 1022-1027;

  3. Rust, G

    1. Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing beta 4 subunits.
      A B Cachelin and G Rust
      Molecular Pharmacology December 1994, 46 (6) 1168-1174;

S

  1. Shih, J C

    1. Cloning of a novel monoamine oxidase cDNA from trout liver.
      K Chen, H F Wu, J Grimsby and J C Shih
      Molecular Pharmacology December 1994, 46 (6) 1226-1233;

  2. Shire, D

    1. Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864.
      R Farges, E Joseph-Liauzun, D Shire, D Caput, G Le Fur and P Ferrara
      Molecular Pharmacology December 1994, 46 (6) 1160-1167;

  3. Simonin, F

    1. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.
      F Simonin, K Befort, C Gavériaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer
      Molecular Pharmacology December 1994, 46 (6) 1015-1021;

  4. Skolnick, P

    1. Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells.
      G Wong, T Lyon and P Skolnick
      Molecular Pharmacology December 1994, 46 (6) 1056-1062;

  5. Sott, C

    1. Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells.
      A Ahlers, C Belka, M Gaestel, N Lamping, C Sott, F Herrmann and M A Brach
      Molecular Pharmacology December 1994, 46 (6) 1077-1083;

  6. Sreenath, A

    1. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
      H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
      Molecular Pharmacology December 1994, 46 (6) 1063-1069;

  7. Stambolsky, D V

    1. Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction.
      V A Tkachuk, Y S Kuzmenko, T J Resink, D V Stambolsky and V N Bochkov
      Molecular Pharmacology December 1994, 46 (6) 1129-1137;

  8. Stimson, E R

    1. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
      M P Blanton, Y M Li, E R Stimson, J E Maggio and J B Cohen
      Molecular Pharmacology December 1994, 46 (6) 1048-1055;

  9. Stowe, E E

    1. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
      H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
      Molecular Pharmacology December 1994, 46 (6) 1063-1069;

T

  1. Tanaka, H

    1. Paradoxical derepression of collagenase gene expression by the antirheumatic gold compound aurothiomalate.
      Y Makino, H Tanaka and I Makino
      Molecular Pharmacology December 1994, 46 (6) 1084-1089;

  2. Taylor, C W

    1. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors.
      A C Hargreaves, S C Lummis and C W Taylor
      Molecular Pharmacology December 1994, 46 (6) 1120-1128;

  3. Teboul, L

    1. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
      A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
      Molecular Pharmacology December 1994, 46 (6) 1070-1076;

  4. Tkachuk, V A

    1. Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction.
      V A Tkachuk, Y S Kuzmenko, T J Resink, D V Stambolsky and V N Bochkov
      Molecular Pharmacology December 1994, 46 (6) 1129-1137;

  5. Tsutsui, M

    1. Correlation of activation of Ca2+/calmodulin-dependent protein kinase II with catecholamine secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells.
      M Tsutsui, N Yanagihara, E Miyamoto, A Kuroiwa and F Izumi
      Molecular Pharmacology December 1994, 46 (6) 1041-1047;

V

  1. Verner, K

    1. Doxorubicin, daunorubicin, and mitoxantrone cytotoxicity in yeast.
      C Kule, O Ondrejickova and K Verner
      Molecular Pharmacology December 1994, 46 (6) 1234-1240;

W

  1. Waelbroeck, M

    1. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
      G Ferrari-Dileo, M Waelbroeck, D C Mash and D D Flynn
      Molecular Pharmacology December 1994, 46 (6) 1028-1035;

  2. Wang, G K

    1. 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
      N A Castle, S R Fadous, D E Logothetis and G K Wang
      Molecular Pharmacology December 1994, 46 (6) 1175-1181;

  3. Weiss, E R

    1. The carboxyl terminus of bovine rhodopsin is not required for G protein activation.
      S Osawa and E R Weiss
      Molecular Pharmacology December 1994, 46 (6) 1036-1040;

  4. White, M M

    1. Gating properties of mutant acetylcholine receptors.
      M L Aylwin and M M White
      Molecular Pharmacology December 1994, 46 (6) 1149-1155;

  5. Williams, T D

    1. Glutathione- and glutathione-S-transferase-dependent oxidative desulfuration of the thione xenobiotic diethyldithiocarbamate methyl ester.
      A Madan, T D Williams and M D Faiman
      Molecular Pharmacology December 1994, 46 (6) 1217-1225;

  6. Wong, G

    1. Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells.
      G Wong, T Lyon and P Skolnick
      Molecular Pharmacology December 1994, 46 (6) 1056-1062;

  7. Wu, H F

    1. Cloning of a novel monoamine oxidase cDNA from trout liver.
      K Chen, H F Wu, J Grimsby and J C Shih
      Molecular Pharmacology December 1994, 46 (6) 1226-1233;

Y

  1. Yanagihara, N

    1. Correlation of activation of Ca2+/calmodulin-dependent protein kinase II with catecholamine secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells.
      M Tsutsui, N Yanagihara, E Miyamoto, A Kuroiwa and F Izumi
      Molecular Pharmacology December 1994, 46 (6) 1041-1047;

  2. Young, P

    1. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
      A Ibrahimi, L Teboul, D Gaillard, E Z Amri, G Ailhaud, P Young, M A Cawthorne and P A Grimaldi
      Molecular Pharmacology December 1994, 46 (6) 1070-1076;

Z

  1. Zhan, Q

    1. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
      H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
      Molecular Pharmacology December 1994, 46 (6) 1063-1069;

  2. Zhang, H

    1. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.
      H Zhang, D A Cooney, A Sreenath, Q Zhan, R Agbaria, E E Stowe, A J Fornace and D G Johns
      Molecular Pharmacology December 1994, 46 (6) 1063-1069;
Back to top

In this issue